Avalanche Biotechnologies develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat age-related macular degeneration (AMD) and other ophthalmologic disorders.
http://investors.avalanchebiotech.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Tuesday
LOAD TIME
3.2 seconds
PAGES IN
THIS WEBSITE
2
SSL
EXTERNAL LINKS
0
SITE IP
128.177.96.35
LOAD TIME
3.234 sec
SCORE
6.2
Avalanche Biotechnologies | Investor Overview | investors.avalanchebiotech.com Reviews
https://investors.avalanchebiotech.com
Avalanche Biotechnologies develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat age-related macular degeneration (AMD) and other ophthalmologic disorders.
investors.avalanchebiotech.com
Adverum Biotechnologies | Investors | Investor Overview
http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-irhome
We Care About You. Adverum Biotechnologies NASDAQ: ADVM. Data provided by Nasdaq. Minimum 15 minutes delayed. Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye. Adverum Biotechnologies, Inc. Reports Second Quarter 2016 Financial Results. Adverum Biotechnologies Provides wet AMD Program Update. Adverum Biotechnologies Appoints Leone Patterson as Chief Financial Officer. There are currently no events scheduled. We Care About You.
Adverum Biotechnologies | Investors | Stock Quote
http://investors.avalanchebiotech.com/phoenix.zhtml?c=253634&p=irol-stockquote
We Care About You. 160; 0.16. Data as of 08/19/16 4:00 pm ET. Data provided by Nasdaq. Minimum 15 minutes delayed. Financial Statements and SEC Filings. We Care About You.
TOTAL PAGES IN THIS WEBSITE
2
Overview - Audentes Therapeutics
Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. 160;at 5:00 pm PT. Audentes Therapeutics Inc at 35th Annula J.P Morgan Healthcare Conference. Tuesday, January 10, 2017 . 5:00 pm PT . Click here for webcast. Click here to add this event to your calendar. Data as of 01/11/17 4:00 pm ET. Audentes Therapeutics Provides Full Year 2017 Strategic Outlook and Financial Guidance. Audentes Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference.
Autodesk - Investor Relations - Investors
Autodesk 2D and 3D Design and Engineering Software. Q2 2016 Autodesk, Inc. Earnings Conference Call. 160;at 2:00 pm PT. Autodesk Second Quarter 2016 Earnings Call will be held on August 27, 2015 at 2:00pm Pacific Time. For the webcast, click here. Autodesk Investor Day 2015. September 29, 2015. Founded in 1982, Autodesk is headquartered in San Rafael, California. Investor Relations Program Specialist. Telephone: 415.507.6373. San Rafael, California 94903. 08/07/15 4:00 pm ET. Pricing delayed 20 minutes.
AutoNation - Investor Relations - Investor Relations Home
Bringing the mid-size truck into the 21st century. AutoNation Announces Reported Retail New Vehicle Unit Sales of 29,875 in July 2015, Up 9% versus July 2014. AutoNation Reports Record Second Quarter EPS from Continuing Operations. AutoNation expects to announce August 2015 reported retail new vehicle unit sales on Wednesday, September 2, 2015. Energy and Autos Forum Town Hall Meeting. More Events and Presentations. Report of unscheduled material events or corporate event. AutoNation, Inc. (NYSE:AN).
investors.autosportsgroup.com.au
Error 404 Page Not Found
This page is currently unavailable. Sorry the page you were looking for appears to have been moved, deleted or does not exist. Please check the web address and try again.
AVAGO - Company - Investor Center - Investor Center
My Avago Account :. My Avago Account :. Q3 2015 Avago Technologies Ltd Earnings Conference Call. 160;at 2:00 pm PT. Avago to Acquire Broadcom. The combination of Avago and Broadcom creates the world's leading diversified communications semiconductor company with combined annual revenues of approximately $15 billion. Avago to Acquire Broadcom Investor Presentation. With a heritage of innovation and a global presence, learn about the company's business model and end markets. Company Overview May 2015.
investors.avalanchebiotech.com
Avalanche Biotechnologies | Investor Overview
Avalanche is a biopharmaceutical company committed to improving or preserving the sight of people with serious eye diseases with an unmet medical need. Using a next generation gene therapy platform, the Ocular BioFactory , the Company is developing product candidates designed to provide long-term efficacy by inducing a sustained expression of a therapeutic protein with the potential for a one-time administration in the eye. 160; 3.82. Data as of 08/14/15 4:00 pm ET. Minimum 15 minute delay. MENLO PARK, C...
Investors | Avery Dennison
You can find more information on a particular business or product by visiting the sites below. Select Region / Language. Label and Packaging Materials. Argentina and Uruguay (Español). Brazil and Paraguay - Brasil e Paraguai (Português). Select Region / Language. Retailing Branding and Information Solutions. Spain - Español de España. Español de Latino América. Durable Goods and Equipment. Supply Chain and Logistics. Research and Development Center Sites. Label and Packaging Materials. Job Search U.S.
AVG - Security Technology | Investors
The only premium security software that actively seeks out identity theft. Ultimate protection for everything you do online. Exceptional protection that won’t get in your way. Get the most out of your PC. Protect your family online. Check website’s reputation online. It’s an inbox. It’s a social feed. It’s a browser. Hassle-free help for your AVG Software, PC and gadgets. AVG Mobilation For Android Smartphones. AVG Mobilation For Android Tablet. AVG Internet Security Business Edition. Q2 2015 AVG Technol...
Investor Relations - AV Homes, Inc.
Media Inquiry information for AV Homes. AV Homes, Inc. Continue to Investor Relations. Welcome to the AV Homes, Inc. Investor Information Web site. Please read the information below carefully before using this site. By continuing on this site, you acknowledge that you have read and agree to the following:. No Duty to Update -. Annual Reports and Proxies. College Station, TX 77842-3170. Toll Free: (800) 850 3132. International: 1 (201) 680 6578. Jul 30, 2015. Jul 16, 2015. View all ». AV Homes, Inc.
Investor Relations | Aviat Networks
Skip to main navigation. Or join the dialogue at www.twitter.com/aviatnetworks. View our Investor video. Feb 8, 2018. Aviat Networks Announces Second Quarter of Fiscal 2018 Financial Results. Feb 1, 2018. Aviat Networks Sets Date for Its Fiscal 2018 Second Quarter Results. More events are coming soon. View all events and presentations. Stock Price/Detail AVNW (NASDAQ).
Avinger - Investor Relations
Avinger Inc at Canaccord Genuity 35th Annual Growth Conference. 160;at 9:00 am ET. Avinger Inc at Canaccord Genuity 35th Annual Growth Conference. Thursday, August 13, 2015 . 9:00 am ET . Click here for webcast. Click here to add this event to your calendar. 160; 0.55. Data as of 08/14/15 4:00 pm ET. Minimum 20 minute delay. Avinger, Inc. Announces Early 510(k) Filing for Pantheris(TM). Avinger, Inc. Announces Participation in Canaccord Genuity 35th Annual Growth Conference. Avinger, Inc. to Announc...
SOCIAL ENGAGEMENT